Evidence map›Paper›PMID 8386704›Full record

ArticleInfection and immunity1993

Kupffer cell elimination enhances development of liver schizonts of Plasmodium berghei in rats.

S G Vreden, R W Sauerwein, J P Verhave, N Van Rooijen, J H Meuwissen, M F Van Den Broek

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Elucidating Spatially-Resolved Changes in Host Signaling DuringFrontiers in cellular and infection microbiology · 2021
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Oncolytic viral therapies.Cancer gene therapy · 2004
    Review
  10. Article
  11. Selectively replicating viral vectors.Cancer gene therapy · 2002
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Methods for assessing splenic macrophage depletion by liposome encapsulated clodronate.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 1995
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

S G VredenDepartment of Medical Microbiology, Nijmegen University Hospital, Nijmegen, The Netherlands.
R W Sauerwein
J P Verhave
N Van Rooijen
J H Meuwissen
M F Van Den Broek
Radboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the development of exoerythrocytic forms (EEF) of Plasmodium berghei in livers of normal and macrophage-depleted Brown Norway rats. Macrophages were depleted by use of liposome-encapsulated dichloromethylene diphosphonate. Upon inoculation of sporozoites, macrophage-depleted rats had significantly larger numbers of EEF than untreated rats. We also investigated the effect of macrophage impairment by silica treatment on the development of EEF and confirmed that silica induces a significant reduction of EEF development. Intravenous administration of silica induced high levels of interleukin-6 in plasma within a few hours. The seemingly contradictory results for EEF development may be explained by our previous observation that interleukin-6 strongly inhibits sporozoite penetration and EEF development in vivo. We conclude that in experimental infections with sporozoites, Kupffer cells inhibit rather than enhance EEF development.

Indexed as

AnimalsInterleukin-6Kupffer CellsLiposomesLiverMacrophagesMalariaMalePlasmodium bergheiRatsRats, Inbred BNSilicon DioxideInterleukin-6LiposomesSilicon Dioxide

Identifiers

PMID8386704
PMCPMC280786
OpenAlexW1902223278

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.